 | • レポートコード：QFJ1-4321 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、院内感染治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗真菌剤）、用途別市場規模（尿路感染症、人工呼吸器関連肺炎、手術部位感染症、血流感染症、その他院内感染）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・院内感染治療の市場動向 ・企業の競争状況、市場シェア ・院内感染治療の種類別市場規模と予測2016-2027（抗菌剤、抗ウイルス剤、抗真菌剤） ・院内感染治療の用途別市場規模と予測2016-2027（尿路感染症、人工呼吸器関連肺炎、手術部位感染症、血流感染症、その他院内感染） ・院内感染治療の北米市場規模2016-2027（アメリカ、カナダ） ・院内感染治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・院内感染治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・院内感染治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・院内感染治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Pfizer、Bayer、GlaxoSmithKline、Daiichi Sankyo、AbbVie、Abbott Laboratories、Roche、Jiangsu Hengrui Medicine、Eli Lilly） ・結論 |
A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI). Antifungal therapy (eg, fluconazole, caspofungin, voriconazole, amphotericin B) in some cases are added to empiric antibiotic coverage. Antiviral therapy (eg, ganciclovir, acyclovir) can be used in the treatment of suspected disseminated viral infections.
Market Analysis and Insights: Global Hospital Acquired Infections Therapeutic Market
The global Hospital Acquired Infections Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Infections Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Acquired Infections Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Acquired Infections Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Acquired Infections Therapeutic market.
Global Hospital Acquired Infections Therapeutic Scope and Market Size
Hospital Acquired Infections Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Segment by Application
Urinary Tract Infections
Ventilator-associated Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Pfizer
Bayer
GlaxoSmithKline
Daiichi Sankyo
AbbVie
Abbott Laboratories
Roche
Jiangsu Hengrui Medicine
Eli Lilly
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infections Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibacterial Drugs
1.2.3 Antiviral Drugs
1.2.4 Antifungal Drugs
1.3 Market by Application
1.3.1 Global Hospital Acquired Infections Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Urinary Tract Infections
1.3.3 Ventilator-associated Pneumonia
1.3.4 Surgical Site Infections
1.3.5 Bloodstream Infections
1.3.6 Other Hospital Infections
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections Therapeutic Market Perspective (2016-2027)
2.2 Hospital Acquired Infections Therapeutic Growth Trends by Regions
2.2.1 Hospital Acquired Infections Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hospital Acquired Infections Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Hospital Acquired Infections Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Hospital Acquired Infections Therapeutic Industry Dynamic
2.3.1 Hospital Acquired Infections Therapeutic Market Trends
2.3.2 Hospital Acquired Infections Therapeutic Market Drivers
2.3.3 Hospital Acquired Infections Therapeutic Market Challenges
2.3.4 Hospital Acquired Infections Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections Therapeutic Players by Revenue
3.1.1 Global Top Hospital Acquired Infections Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Hospital Acquired Infections Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Hospital Acquired Infections Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Infections Therapeutic Revenue
3.4 Global Hospital Acquired Infections Therapeutic Market Concentration Ratio
3.4.1 Global Hospital Acquired Infections Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections Therapeutic Revenue in 2020
3.5 Hospital Acquired Infections Therapeutic Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Infections Therapeutic Product Solution and Service
3.7 Date of Enter into Hospital Acquired Infections Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Infections Therapeutic Breakdown Data by Type
4.1 Global Hospital Acquired Infections Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Hospital Acquired Infections Therapeutic Forecasted Market Size by Type (2022-2027)
5 Hospital Acquired Infections Therapeutic Breakdown Data by Application
5.1 Global Hospital Acquired Infections Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Hospital Acquired Infections Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hospital Acquired Infections Therapeutic Market Size (2016-2027)
6.2 North America Hospital Acquired Infections Therapeutic Market Size by Type
6.2.1 North America Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Hospital Acquired Infections Therapeutic Market Size by Type (2016-2027)
6.3 North America Hospital Acquired Infections Therapeutic Market Size by Application
6.3.1 North America Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Hospital Acquired Infections Therapeutic Market Size by Application (2016-2027)
6.4 North America Hospital Acquired Infections Therapeutic Market Size by Country
6.4.1 North America Hospital Acquired Infections Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Hospital Acquired Infections Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hospital Acquired Infections Therapeutic Market Size (2016-2027)
7.2 Europe Hospital Acquired Infections Therapeutic Market Size by Type
7.2.1 Europe Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Hospital Acquired Infections Therapeutic Market Size by Type (2016-2027)
7.3 Europe Hospital Acquired Infections Therapeutic Market Size by Application
7.3.1 Europe Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Hospital Acquired Infections Therapeutic Market Size by Application (2016-2027)
7.4 Europe Hospital Acquired Infections Therapeutic Market Size by Country
7.4.1 Europe Hospital Acquired Infections Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Hospital Acquired Infections Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Type
8.2.1 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Application
8.3.1 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Region
8.4.1 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hospital Acquired Infections Therapeutic Market Size (2016-2027)
9.2 Latin America Hospital Acquired Infections Therapeutic Market Size by Type
9.2.1 Latin America Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Hospital Acquired Infections Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Hospital Acquired Infections Therapeutic Market Size by Application
9.3.1 Latin America Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Hospital Acquired Infections Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Hospital Acquired Infections Therapeutic Market Size by Country
9.4.1 Latin America Hospital Acquired Infections Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Hospital Acquired Infections Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Type
10.2.1 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Application
10.3.1 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Country
10.4.1 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Hospital Acquired Infections Therapeutic Introduction
11.1.4 Merck Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Hospital Acquired Infections Therapeutic Introduction
11.2.4 Pfizer Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Hospital Acquired Infections Therapeutic Introduction
11.3.4 Bayer Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Hospital Acquired Infections Therapeutic Introduction
11.4.4 GlaxoSmithKline Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Hospital Acquired Infections Therapeutic Introduction
11.5.4 Daiichi Sankyo Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.5.5 Daiichi Sankyo Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Hospital Acquired Infections Therapeutic Introduction
11.6.4 AbbVie Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Hospital Acquired Infections Therapeutic Introduction
11.7.4 Abbott Laboratories Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.7.5 Abbott Laboratories Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Hospital Acquired Infections Therapeutic Introduction
11.8.4 Roche Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Details
11.9.2 Jiangsu Hengrui Medicine Business Overview
11.9.3 Jiangsu Hengrui Medicine Hospital Acquired Infections Therapeutic Introduction
11.9.4 Jiangsu Hengrui Medicine Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.9.5 Jiangsu Hengrui Medicine Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Hospital Acquired Infections Therapeutic Introduction
11.10.4 Eli Lilly Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021)
11.10.5 Eli Lilly Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hospital Acquired Infections Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibacterial Drugs
Table 3. Key Players of Antiviral Drugs
Table 4. Key Players of Antifungal Drugs
Table 5. Global Hospital Acquired Infections Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hospital Acquired Infections Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hospital Acquired Infections Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hospital Acquired Infections Therapeutic Market Share by Regions (2016-2021)
Table 9. Global Hospital Acquired Infections Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hospital Acquired Infections Therapeutic Market Share by Regions (2022-2027)
Table 11. Hospital Acquired Infections Therapeutic Market Trends
Table 12. Hospital Acquired Infections Therapeutic Market Drivers
Table 13. Hospital Acquired Infections Therapeutic Market Challenges
Table 14. Hospital Acquired Infections Therapeutic Market Restraints
Table 15. Global Hospital Acquired Infections Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hospital Acquired Infections Therapeutic Market Share by Players (2016-2021)
Table 17. Global Top Hospital Acquired Infections Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infections Therapeutic as of 2020)
Table 18. Ranking of Global Top Hospital Acquired Infections Therapeutic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hospital Acquired Infections Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hospital Acquired Infections Therapeutic Product Solution and Service
Table 22. Date of Enter into Hospital Acquired Infections Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hospital Acquired Infections Therapeutic Revenue Market Share by Type (2016-2021)
Table 26. Global Hospital Acquired Infections Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hospital Acquired Infections Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hospital Acquired Infections Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hospital Acquired Infections Therapeutic Revenue Market Share by Application (2016-2021)
Table 30. Global Hospital Acquired Infections Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hospital Acquired Infections Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hospital Acquired Infections Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hospital Acquired Infections Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hospital Acquired Infections Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hospital Acquired Infections Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hospital Acquired Infections Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hospital Acquired Infections Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hospital Acquired Infections Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hospital Acquired Infections Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Hospital Acquired Infections Therapeutic Product
Table 65. Merck Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Hospital Acquired Infections Therapeutic Product
Table 70. Pfizer Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Bayer Company Details
Table 73. Bayer Business Overview
Table 74. Bayer Hospital Acquired Infections Therapeutic Product
Table 75. Bayer Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Hospital Acquired Infections Therapeutic Product
Table 80. GlaxoSmithKline Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Daiichi Sankyo Company Details
Table 83. Daiichi Sankyo Business Overview
Table 84. Daiichi Sankyo Hospital Acquired Infections Therapeutic Product
Table 85. Daiichi Sankyo Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 86. Daiichi Sankyo Recent Development
Table 87. AbbVie Company Details
Table 88. AbbVie Business Overview
Table 89. AbbVie Hospital Acquired Infections Therapeutic Product
Table 90. AbbVie Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 91. AbbVie Recent Development
Table 92. Abbott Laboratories Company Details
Table 93. Abbott Laboratories Business Overview
Table 94. Abbott Laboratories Hospital Acquired Infections Therapeutic Product
Table 95. Abbott Laboratories Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 96. Abbott Laboratories Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Jiangsu Hengrui Medicine Company Details
Table 102. Jiangsu Hengrui Medicine Business Overview
Table 103. Jiangsu Hengrui Medicine Hospital Acquired Infections Therapeutic Product
Table 104. Jiangsu Hengrui Medicine Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 105. Jiangsu Hengrui Medicine Recent Development
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Hospital Acquired Infections Therapeutic Product
Table 109. Eli Lilly Revenue in Hospital Acquired Infections Therapeutic Business (2016-2021) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Infections Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Antibacterial Drugs Features
Figure 3. Antiviral Drugs Features
Figure 4. Antifungal Drugs Features
Figure 5. Global Hospital Acquired Infections Therapeutic Market Share by Application: 2020 VS 2027
Figure 6. Urinary Tract Infections Case Studies
Figure 7. Ventilator-associated Pneumonia Case Studies
Figure 8. Surgical Site Infections Case Studies
Figure 9. Bloodstream Infections Case Studies
Figure 10. Other Hospital Infections Case Studies
Figure 11. Hospital Acquired Infections Therapeutic Report Years Considered
Figure 12. Global Hospital Acquired Infections Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Hospital Acquired Infections Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hospital Acquired Infections Therapeutic Market Share by Regions: 2020 VS 2027
Figure 15. Global Hospital Acquired Infections Therapeutic Market Share by Regions (2022-2027)
Figure 16. Global Hospital Acquired Infections Therapeutic Market Share by Players in 2020
Figure 17. Global Top Hospital Acquired Infections Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infections Therapeutic as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Hospital Acquired Infections Therapeutic Revenue in 2020
Figure 19. Global Hospital Acquired Infections Therapeutic Revenue Market Share by Type (2016-2021)
Figure 20. Global Hospital Acquired Infections Therapeutic Revenue Market Share by Type (2022-2027)
Figure 21. North America Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Hospital Acquired Infections Therapeutic Market Share by Type (2016-2027)
Figure 23. North America Hospital Acquired Infections Therapeutic Market Share by Application (2016-2027)
Figure 24. North America Hospital Acquired Infections Therapeutic Market Share by Country (2016-2027)
Figure 25. United States Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hospital Acquired Infections Therapeutic Market Share by Type (2016-2027)
Figure 29. Europe Hospital Acquired Infections Therapeutic Market Share by Application (2016-2027)
Figure 30. Europe Hospital Acquired Infections Therapeutic Market Share by Country (2016-2027)
Figure 31. Germany Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hospital Acquired Infections Therapeutic Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Hospital Acquired Infections Therapeutic Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Hospital Acquired Infections Therapeutic Market Share by Region (2016-2027)
Figure 41. China Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hospital Acquired Infections Therapeutic Market Share by Type (2016-2027)
Figure 49. Latin America Hospital Acquired Infections Therapeutic Market Share by Application (2016-2027)
Figure 50. Latin America Hospital Acquired Infections Therapeutic Market Share by Country (2016-2027)
Figure 51. Mexico Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hospital Acquired Infections Therapeutic Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Hospital Acquired Infections Therapeutic Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Hospital Acquired Infections Therapeutic Market Share by Country (2016-2027)
Figure 57. Turkey Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Hospital Acquired Infections Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Merck Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 65. AbbVie Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 66. Abbott Laboratories Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 68. Jiangsu Hengrui Medicine Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Hospital Acquired Infections Therapeutic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の後天性感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Infections Testing Market The global Acquired Infections Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…- 世界の院内感染 (HAI) 診断市場規模・現状・予測（2021年-2027年） A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infectio…
- 世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年） Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in…
- 世界の人工関節感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 耐性緑膿菌感染症薬のグローバル市場調査 2019年 The global Resistant Pseudomonas Aeruginosa Infections Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Resistant Pseudomonas Aeruginosa Infections Drugs volume and value at global level, regio…